Adaptive Biotechnologies adaptivebiotech.com

Adaptive Biotechnologies (NASDAQ: ADPT) focuses on immunosequencing diagnostics, specifically in oncology. The company leverages advances in sequencing to profile T-Cell and B-Cell Receptors. This enables in-depth characterization of the immune system, which is the primary defense against cancer. By incorporating immunosequencing into clinical care, Adaptive can enhance the diagnosis, prognosis, and monitoring of cancer patients.

Adaptive Biotechnologies (NASDAQ: ADPT) focuses on immunosequencing diagnostics, specifically in oncology. The company leverages advances in sequencing to profile T-Cell and B-Cell Receptors. This enables in-depth characterization of the immune syste...Show all

See All Exits Recent Exits

Phone: 206-659-0067

Fax:

1551 Eastlake Ave E
Ste 200
Seattle, 98102
Washington, United States

Adaptive Biotechnologies - Investments & Acquisitions

Show Real Data Adaptive Biotechnologies Investments
See all Recent Investments
Date Company Round Amount Co-investors
2015-01-07SequentaAcquired
See all 1 investments